Bank of New York Mellon’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.94M | Buy |
484,053
+82,483
| +21% | +$671K | ﹤0.01% | 2397 |
|
|
2025
Q1 | $3.15M | Buy |
401,570
+19,955
| +5% | +$157K | ﹤0.01% | 2439 |
|
|
2024
Q4 | $5.68M | Buy |
381,615
+30,290
| +9% | +$451K | ﹤0.01% | 2214 |
|
|
2024
Q3 | $5.37M | Sell |
351,325
-44,541
| -11% | -$681K | ﹤0.01% | 2260 |
|
|
2024
Q2 | $6.03M | Sell |
395,866
-4,303
| -1% | -$65.5K | ﹤0.01% | 2238 |
|
|
2024
Q1 | $7.56M | Sell |
400,169
-17,585
| -4% | -$332K | ﹤0.01% | 2110 |
|
|
2023
Q4 | $7.98M | Sell |
417,754
-30,828
| -7% | -$589K | ﹤0.01% | 2111 |
|
|
2023
Q3 | $8.05M | Sell |
448,582
-11,638
| -3% | -$209K | ﹤0.01% | 2063 |
|
|
2023
Q2 | $9.35M | Sell |
460,220
-18,180
| -4% | -$369K | ﹤0.01% | 1980 |
|
|
2023
Q1 | $8.73M | Sell |
478,400
-10,051
| -2% | -$183K | ﹤0.01% | 1997 |
|
|
2022
Q4 | $10.1M | Buy |
488,451
+17,755
| +4% | +$367K | ﹤0.01% | 1937 |
|
|
2022
Q3 | $12.3M | Buy |
470,696
+47,247
| +11% | +$1.24M | ﹤0.01% | 1774 |
|
|
2022
Q2 | $10.7M | Buy |
423,449
+212,614
| +101% | +$5.39M | ﹤0.01% | 1893 |
|
|
2022
Q1 | $6.65M | Sell |
210,835
-29,229
| -12% | -$922K | ﹤0.01% | 2276 |
|
|
2021
Q4 | $9.72M | Buy |
240,064
+19,671
| +9% | +$796K | ﹤0.01% | 2116 |
|
|
2021
Q3 | $7.69M | Buy |
220,393
+16,982
| +8% | +$592K | ﹤0.01% | 2260 |
|
|
2021
Q2 | $5.59M | Buy |
203,411
+33,662
| +20% | +$924K | ﹤0.01% | 2432 |
|
|
2021
Q1 | $4.77M | Sell |
169,749
-12,814
| -7% | -$360K | ﹤0.01% | 2465 |
|
|
2020
Q4 | $4.74M | Buy |
182,563
+18,966
| +12% | +$492K | ﹤0.01% | 2389 |
|
|
2020
Q3 | $2.81M | Sell |
163,597
-5,794
| -3% | -$99.3K | ﹤0.01% | 2488 |
|
|
2020
Q2 | $4.19M | Buy |
169,391
+20,147
| +13% | +$498K | ﹤0.01% | 2295 |
|
|
2020
Q1 | $2.07M | Buy |
149,244
+24,179
| +19% | +$336K | ﹤0.01% | 2523 |
|
|
2019
Q4 | $1.26M | Buy |
125,065
+141
| +0.1% | +$1.42K | ﹤0.01% | 3110 |
|
|
2019
Q3 | $1.14M | Buy |
124,924
+7,941
| +7% | +$72.2K | ﹤0.01% | 3100 |
|
|
2019
Q2 | $930K | Buy |
116,983
+9,980
| +9% | +$79.3K | ﹤0.01% | 3262 |
|
|
2019
Q1 | $1.34M | Buy |
107,003
+6,766
| +7% | +$84.5K | ﹤0.01% | 2992 |
|
|
2018
Q4 | $1.08M | Buy |
100,237
+79,052
| +373% | +$852K | ﹤0.01% | 3058 |
|
|
2018
Q3 | $295K | Buy |
21,185
+5,138
| +32% | +$71.5K | ﹤0.01% | 3821 |
|
|
2018
Q2 | $196K | Buy |
+16,047
| New | +$196K | ﹤0.01% | 3919 |
|